Azole Resistance in Aspergillus fumigatus Infections Remains Low in Germany and Is Mainly Related to Environmental Resistance Mutations
Mycoses · 2026-11 · 69 (11)
DOI: 10.1111/myc.70251 ↗Kurz gefasst
Fachartikel in der Zeitschrift Mycoses, online erschienen am 18.11.2026. Verfasst von Anja von Laer und 11 weiteren Autor:innen. Die Arbeit nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Bundesministerium für Gesundheit, European Social Fund Plus.
Abstract (Originalsprache)
Background
Aspergillus fumigatus can cause life‐threatening infections, primarily treated with azole antifungals. Azole‐resistant A. fumigatus (ARAF) is a major clinical concern. Environmental resistance development is an important driver, mainly associated with L98H mutations in the cyp51A gene.
Objectives
We describe ARAF proportions and resistance genotypes in systematically collected German data between 2020 and 2024 to inform empiric treatment and public health measures.
Methods
Two national data sets were analysed: (1) routine diagnostic data on A. fumigatus submitted to a voluntary laboratory‐based surveillance system (ARS) covering approximately one‐third of the German population to determine resistance proportions; and (2) typing data from isolates voluntarily submitted to the National Reference Center (NRZMyk) to determine ARAF genotype distribution.
Results
Of 17,853 A. fumigatus isolates reported in ARS from continuously participating facilities, 1124 (6.3%) were evaluated for voriconazole susceptibility. Of those, 1.2% (0.7%–2.1%) were found resistant. Resistance proportions varied by year from 0.0% (0.0%–2.5%) in 2024 to 3.7% (1.6%–8.3%) in 2023 and by region from 0.7% (0.1%–3.6%) in western Germany and 1.6% (0.6%–4.7%) in southeastern Germany. Among 139 isolates typed at NRZMyk, TR 34 /L98H predominated (63%). Mutations considered environmentally driven were found in 83% of ARAF.
Conclusion
The overall ARAF proportion in Germany between 2020 and 2024 was low (1.2%). TR 34 /L98H predominated, suggesting mainly environmental resistance development. Higher resistance may occur locally and in specific patient groups. Continuous local and national surveillance is essential to guide antimicrobial stewardship.
Förderung
- Bundesministerium für Gesundheit
- European Social Fund Plus
Zitieren
APA
Laer, A. V., Walther, G., Reichert, F., Noll, I., Feig, M., Schneider, M., Eckmanns, T., Hoffmann, A., Aldejohann, A. M., Aehlig, O., Gyr, L., & Kurzai, O. (2026). Azole Resistance in Aspergillus fumigatus Infections Remains Low in Germany and Is Mainly Related to Environmental Resistance Mutations. Mycoses, 69(11). https://doi.org/10.1111/myc.70251
Vancouver
Laer AV, Walther G, Reichert F, Noll I, Feig M, Schneider M, et al. Azole Resistance in Aspergillus fumigatus Infections Remains Low in Germany and Is Mainly Related to Environmental Resistance Mutations. Mycoses. 2026;69(11). doi:10.1111/myc.70251
BibTeX
@article{Laer2026,
author = {Laer, Anja von and Walther, Grit and Reichert, Felix and Noll, Ines and Feig, Marcel and Schneider, Marc and Eckmanns, Tim and Hoffmann, Alexandra and Aldejohann, Alexander M. and Aehlig, Oliver and Gyr, Luzia and Kurzai, Oliver},
title = {Azole Resistance in Aspergillus fumigatus Infections Remains Low in Germany and Is Mainly Related to Environmental Resistance Mutations},
journal = {Mycoses},
year = {2026},
volume = {69},
number = {11},
doi = {10.1111/myc.70251}
}
EUVIMED